PRLOG

Title

Pharmaceuticals | Bayer - Home

Keywords

n/a

Description

n/a

Кодировка

UTF-8

Размер страницы

92.25 КБ

Количество слов

715

Длина текста на странице

5 767 симв.

Длина текста без пробелов

4 936 симв.

<H1>

<H2>

• News

<H3>

• Targeting AhR: A promising new approach to cancer immunotherapy
• The Impact of Prostate Cancer Treatment on Patients’ Everyday Life
• Discover “The Sonifex Mystery” – New online game
• P2X3 Antagonists - potential treatments for endometriosis and chronic cough
• New treatment for non-metastatic castration-resistant prostate cancer approved i...
• What will the future of healthcare look like?
• Watch the live recording of the Silver Economy Forum 2019
• by Robert LaCaze
• Our oncology development pipeline
• by Stefan Oelrich
• by Dr. Michael Devoy
• by Sebastian Guth
• Genomic Cancer Testing: See the Real Picture of a Cancer Diagnosis
• by Joerg Moeller
• by Stefan Oelrich
• The promise of immuno-oncology
• Targeting cancer via its DNA
• An interview with Broad Institute scientist, Steven Ferrara
• Potential for patients with difficult-to-treat tumors
• How genomic testing helps patients
• Rising concerns for pharmaceutical innovation in Japan
• What is TRK fusion cancer and how can we detect it?
• Testing for TRK fusion cancer
• Benefits and risks of drugs
• The first treatment for TRK fusion cancer approved by U.S. FDA
• Looking after yourself while caring for a loved one
• What you might not know about heart and blood scans
• The future of cancer therapy is now
• Living with prostate cancer
• What you need to know about cancer genomics
• Drug development: The R&D journey
• Healthy aging
• Health policy
• Why we partner
• How partnerships in research and development can help
• – agnostic therapy in Europe
• Chagas Disease
• Find out more here: https://www.bridge2.bayer.com
• : Congratulations to our Head of Business Development & Licensing @MDDBacker on ...
• Fish Soup | Easy Healthy Recipes #10
• Bayer trial finder
• Clinicaltrials.gov
• Data sharing portal
• Latest press release
• Find us in your country
• Bayer submits application to EMA for use of rivaroxaban in children with venous ...
• Bayer expands collaboration with the World Health Organization to fight pork tap...
• Phase III VICTORIA study with vericiguat in patients with worsening chronic hear...
• Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovas...
• Bayer: Encouraging business performance across all divisions – agreements signed...

Анализ текста

• 3.50% ( 25 ) treatment
• 2.66% ( 19 ) innovation
• 2.66% ( 19 ) partnering
• 2.38% ( 17 ) care
• 2.24% ( 16 ) cancer
• 2.10% ( 15 ) orange
• 1.96% ( 14 ) bayer
• 1.96% ( 14 ) blue
• 1.82% ( 13 ) health
• 1.26% ( 9 ) development
• 1.26% ( 9 ) disease
• 1.26% ( 9 ) patient
• 1.12% ( 8 ) with
• 0.98% ( 7 ) commitment
• 0.98% ( 7 ) green
• 0.84% ( 6 ) heart
• 0.84% ( 6 ) responsibility
• 0.70% ( 5 ) drug
• 0.70% ( 5 ) what
• 0.56% ( 4 ) areas

Данные предоставлены сервисом semrush

Сайт	Общие фразы	PR	тИЦ	Alexa Rank	Alexa Country
bayer.com	87	7	200	57810	28085
cvphysiology.com	79	5	10	102217	26797
bayerus.com	49	6	10	Нет данных	Нет данных
bayerhealthcare.com	38	6	40	1275609	582287
ukrocharity.org	36	3	0	2028179	536228
amcp.org	33	6	10	305193	56303
bayercare.com	23	5	0	967388	421885
jra.sagepub.com	23	6	10	1673	1382
bayercropscience.us	20	5	10	Нет данных	Нет данных
handwrittentutorials.com	15	3	0	517379	512261
wikipedia.org	11	9	0	5	6
nih.gov	7	8	0	113	65
youtube.com	3	9	0	2	2
patient.co.uk	3	6	0	19976462	Нет данных
phrma.org	3	7	0	364326	97389
pfizer.com	3	7	0	34888	14501
novartis.com	3	7	100	66520	24717
nature.com	3	9	0	740	269
centerwatch.com	3	7	20	117553	35782
Еще 31 сайт после авторизации

Данные предоставлены сервисом semrush

Domain Name: BAYERPHARMA.COM
Registry Domain ID: 9432313_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://www.cscglobal.com/global/web/csc/digital-brand-services.html
Updated Date: 2018-01-24T14:57:55Z
Creation Date: 1999-08-24T19:02:46Z
Registry Expiry Date: 2019-08-24T19:02:45Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: PDNS1.CSCDNS.NET
Name Server: PDNS2.CSCDNS.NET

URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-11-11T19:57:52Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

IP адрес

США - Аврора - 204.12.74.58

Организация

HostMySite

Интернет провайдер

HostMySite

HTTP/1.1 200 OK
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate
Pragma: no-cache
HCVer: 111
Content-Type: text/html; charset=utf-8
HAVer: 121
Date: Sun, 15 Dec 2019 23:03:16 GMT
Transfer-Encoding: chunked
Connection: keep-alive
Connection: Transfer-Encoding
Set-Cookie: PHPSESSID=fYj1RdGbO2YUO6eIh1nY91; expires=Mon, 16-Dec-2019 00:03:16 GMT; Max-Age=3600; path=/; HttpOnly
Set-Cookie: WHGACE=ffffffff09b6a18545525d5f4f58455e445a4a423660;expires=Mon, 16-Dec-2019 23:03:16 GMT;path=/;httponly

Проиндексирован

• Mail.ru
• Yahoo.com
• Bing.com
• Картинки Google
• Картинки Yandex

Ссылаются

• Яндекс Блоги
• Google Блоги
• Bing.com
• Ответы Mail.ru
• Записи Twitter.com

Дополнительные ссылки

• Все сайты на этом IP
• Сохраненная копия Google
• Проверка склейки
• Проверка валидности HTML
• Проверка валидности CSS
• Ping / Traceroute / DNS
• История сайта
• История владельцев